Arkle Resources pivots to uranium in Namibia post year-end, sharpening its energy metals focus and giving investors a clearer, higher-risk exploration story.
This article covers information on Arkle Resources PLC.
LON:ARKArkle Resources’ preliminary results for 2025 are one of those updates where the historic numbers matter, but the real story sits just after the year end. Strip away the corporate language and this is a small explorer that has decided to pivot hard into uranium, using a Namibia deal to reshape the investment case.
For retail investors, that is the big takeaway. The 2025 accounts show a cleaner loss, more cash and active projects in Ireland and Botswana, but the market will mostly judge Arkle on whether its new Namibia uranium push can turn early promise into drill success.
| Metric | 2025 | 2024 |
|---|---|---|
| Loss for the year | €498,492 | €2,001,750 |
| Administrative expenses | €225,244 | €271,223 |
| Cash and cash equivalents | €297,979 | €27,303 |
| Net assets | €2,021,651 | €1,982,749 |
| Exploration and evaluation assets | €2,529,885 | €2,570,085 |
| Basic and diluted loss per share | 0.08 cents | 0.43 cents |
On the face of it, the financial performance improved. The loss narrowed sharply to €498,492 from €2,001,750, but there is an important catch: 2024 was hit by a €1,769,948 impairment charge, while 2025 had no equivalent write-down. So yes, the numbers look better, but not because Arkle has suddenly become self-funding or cash generative.
Cash improved materially to €297,979 from just €27,303, helped by a £500,000 placing in July 2025. That gave the company breathing room, but this remains an exploration business that depends on equity funding rather than operating income.
The standout development came after the year end. On 29 January 2026, Arkle announced the acquisition of an 85% interest in Namibia Uranium Pty Ltd for total consideration of £2,032,000, made up of cash and new shares.
That deal gives Arkle four Exclusive Prospecting Licences in Namibia’s Erongo Region, adjacent to major uranium deposits including Trekkopje, Marenica and Rössing. In mining, location matters a lot, and being next door to known deposits is exactly the sort of thing that gets investors interested.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
5 viewsLikes
No ratings yet
The company says sampling carried out by the vendor during 2025 returned uranium grades of up to 3,855 parts per million. That does not prove an economic discovery, but it is enough to justify the market paying attention.
Just as important, Arkle did not waste time. It says geophysical surveys have already been completed and that interpretation has identified multiple high-priority drill targets, with about 4,000 metres of RC drilling planned. RC stands for reverse circulation, a common and relatively fast drilling method used in early-stage exploration.
My view is simple: this is high risk, but it is the right sort of risk for a junior explorer that needs a clearer story. Uranium is a much hotter theme than the company’s older mix of gold, zinc and lithium, and the Namibia pivot gives Arkle a sharper identity.
Even with uranium taking centre stage, Arkle still has other assets that matter. At Stonepark in County Limerick, where it holds a 22.36% interest, partner Group Eleven completed drilling at Carrickittle West and identified two new priority targets, Kilteely and Bruff.
The technical signs described are encouraging, including black matrix breccias, hydrothermal fluid pathways and the first appearance of sphalerite. The project is also only six kilometres from Glencore’s 45 million tonne Pallas Green deposit, which helps explain why management remains upbeat.
In Botswana, the Makgadikgadi Salt Pans lithium project also moved forward. Arkle said all 20 samples tested contained lithium, while eight samples exceeded 1% magnesium. That matters because Direct Lithium Extraction, or DLE, can potentially recover magnesium as a valuable co-product.
The company was also awarded a third prospecting licence covering 775 square kilometres, taking its total Botswana licence area to 1,612 square kilometres. Geophysics extended the confirmed brine system across all three licences, and drilling is expected in 2026.
That is a decent portfolio for a company of this size. Uranium may now lead the story, but zinc and lithium still offer additional upside if drilling goes the right way.
There is a more disciplined side to this update too. At Mine River in County Wicklow, Arkle decided not to renew four gold licences after failing to prove the continuity needed for commerciality.
Donegal is also under review for joint venture, partnership or divestment, even though the target vein was found in all four drill holes. That might sound disappointing, but I actually see this as a positive. Small explorers usually do better when they stop spreading themselves too thin and focus capital where market interest is strongest.
The company flagged net current liabilities of €508,234 at year end. In plain English, short-term liabilities were higher than short-term assets, which is never ideal.
Arkle says it has enough funds for at least the next 12 months and points to the £500,000 raised during 2025, plus a further £1,700,000 placing and £403,000 from warrant exercises after the balance sheet date. That is reassuring in the near term, but investors should not ignore the underlying reality: this business still relies on the market staying willing to provide fresh capital.
Another detail worth noting is that accruals included €352,500 of directors’ remuneration unpaid at year end. That is disclosed plainly in the accounts. It is not unusual for junior resource companies, but it is still something shareholders should keep an eye on.
Funding exploration is expensive, and Arkle has used equity heavily. In July 2025, it issued 166,666,667 shares at 0.30p and attached one warrant per share. By 31 December 2025, the company had 731,477,664 ordinary shares in issue.
Then came even more paper after year end: 305,000,000 consideration shares for the Namibia acquisition, 7,500,000 adviser shares, 425,000,000 placing shares, and additional shares from warrant exercises. The company also granted options over 130,000,000 ordinary shares on 2 April 2026 at an exercise price of 0.95p.
The upside is obvious: Arkle has funded a serious strategic reset. The downside is dilution. Existing shareholders now own a smaller slice of the company, and that is the trade-off with most junior explorers.
I think this is a more interesting company than it was a year ago. The 2025 numbers themselves are fine rather than exciting, but the Namibia uranium acquisition has changed the narrative in a meaningful way.
The positives are clear: a stronger cash position, active projects in three mining jurisdictions, a sharper energy metals focus, and early uranium targets that look credible enough to justify drilling. The negatives are just as clear: no revenue, ongoing funding dependence, heavy dilution and the usual exploration risk that plenty of targets never become mines.
So this RNS matters because it marks Arkle’s move from being a small, scattered explorer into a more focused uranium-led energy metals story. Whether that turns into real shareholder value now depends far less on the 2025 accounts and far more on what the drill bit delivers in Namibia and Botswana during 2026.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.